Literature DB >> 25531052

The role of CT10 regulation of kinase-like in cancer.

Chunmei Guo1, Shuqing Liu, Ming-Zhong Sun.   

Abstract

V-crk avian sarcoma virus CT10 oncogene homolog-like (CRKL) is a member of CRK family. It acts as an adaptor protein in intracellular signal transduction. CRKL has been reported overexpressed in a variety of cancers affecting the aggressive and malignant behaviors of cancer cells. CRKL seems to show a tumor-promotion role in gastric cancer, glioblastoma multiforme, hepatocellular carcinoma, bladder cancer, lung cancer, colon cancer, ovarian cancer, leukemia, breast cancer, head and neck cancer, rhabdomyosarcoma and neuroblastoma. The association of CRKL with malignant tumors and its potential action mechanisms were summarized. CRKL has the potential to be used as a biomarker for the diagnosis, treatment and prognosis of certain tumors.

Entities:  

Keywords:  CRKL; biomarker; cancer; invasion; metastasis

Mesh:

Substances:

Year:  2014        PMID: 25531052     DOI: 10.2217/fon.14.199

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  6 in total

1.  Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.

Authors:  Shaomei Cheng; Jingyan Guo; Qing Yang; Xiangshan Yang
Journal:  Med Oncol       Date:  2015-01-31       Impact factor: 3.064

2.  IL-7-induced phosphorylation of the adaptor Crk-like and other targets.

Authors:  Francesca B Aiello; Tad Guszczynski; Wenqing Li; Julie A Hixon; Qiong Jiang; Deborah L Hodge; Tania Massignan; Chiara Di Lisio; Anand Merchant; Antonio D Procopio; Valentina Bonetto; Scott K Durum
Journal:  Cell Signal       Date:  2018-03-24       Impact factor: 4.315

3.  miR-429 suppresses tumor migration and invasion by targeting CRKL in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and epithelial-mesenchymal transition.

Authors:  Chunmei Guo; Dongting Zhao; Qiuling Zhang; Shuqing Liu; Ming-Zhong Sun
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

4.  A novel ETV6-miR-429-CRKL regulatory circuitry contributes to aggressiveness of hepatocellular carcinoma.

Authors:  Chunmei Guo; Chao Gao; Dongting Zhao; Jiahui Li; Jinxia Wang; Xujuan Sun; Qinlong Liu; Lihong Hao; Frederick T Greenaway; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Exp Clin Cancer Res       Date:  2020-04-23

5.  CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt.

Authors:  Chunmei Guo; Chao Gao; Xinxin Lv; Dongting Zhao; Frederick T Greenaway; Lihong Hao; Yuxiang Tian; Shuqing Liu; Ming-Zhong Sun
Journal:  J Cell Mol Med       Date:  2021-02-01       Impact factor: 5.310

Review 6.  Crk and CrkL as Therapeutic Targets for Cancer Treatment.

Authors:  Taeju Park
Journal:  Cells       Date:  2021-03-27       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.